Can the 'love hormone' calm anxiety in diabetes insipidus?
NCT ID NCT06036004
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a nasal spray containing oxytocin can help reduce anxiety and improve emotional well-being in adults with central diabetes insipidus, a condition where the body lacks a key hormone. Participants will receive either oxytocin or a placebo spray for several weeks. The goal is to see if oxytocin can ease psychological symptoms beyond standard hormone replacement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL DIABETES INSIPIDUS (CDI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Charité University Medical Center Berlin
RECRUITINGBerlin, 10117, Germany
-
Erasmus University Medical Center Rotterdam
RECRUITINGRotterdam, 3015, Netherlands
-
University Hospital Basel, Department of Endocrinology, Diabetes & Metabolism
RECRUITINGBasel, 4031, Switzerland